Please assess the completion status of the following clinical trial:

Trial Title: Acute Control of Chronic Hypertension

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Age ≥ 18 years~* Gestational age ≥ 24 weeks~* Singleton gestation~* Chronic hypertension as defined as two elevated blood pressures (SBP ≥ 140mmHg and/or DBP ≥ 90mmHg) at least 4 hours apart before 20 weeks gestation~Exclusion Criteria:~* Known allergic reaction to labetalol~* Persistent mild-moderate asthma (≥ 2 rescue inhaler uses per week in the previous month)~* Obstructive airway disease~* Bradycardia \< 70 beats/min~* Heart block \> 1st degree or history of heart failure

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Experimental labetalol dose (Type: EXPERIMENTAL): Subjects receive 40mg, 60mg, 80mg after each severe BP
- Current standard of care (Type: ACTIVE_COMPARATOR): Subjects receive 20mg, 40mg, 60mg after each severe BP

Based on this trial design, predict the completion outcome and termination type (if applicable).